Related by context. All words. (Click for frequent words.) 83 mg dL 72 #mg/dl 71 mmHg 70 mmol l 69 ng dL 69 ng mL 69 mmol L 69 #mg/dL [001] 69 pg mL 68 mm Hg 68 nmol L 68 ng ml 67 g dL 66 fasting blood glucose 66 mEq L 65 mm Hg systolic 65 glycated hemoglobin 65 #mmHg [002] 65 mL/min/#.# m 2 64 per deciliter mg 64 HbA 1c 64 pg ml 64 mmHg systolic 64 #.#mmol L [002] 63 mmol liter 63 HbA1c 63 #mmHg [001] 63 umol L 63 g dl 63 fasting glucose 63 μmol L 63 #.#mmol l [002] 63 HbA1c levels 62 hemoglobin A1c HbA1c 62 mg d 62 serum potassium 62 plasma glucose levels 62 mmHg diastolic 62 #mg/dL [002] 62 -#.# mg dL [002] 62 pmol L 62 cholesterol LDL C 62 baseline HbA1c 61 systolic BP 61 fasting plasma glucose 61 mIU L 61 mmol L. 61 nmol liter 61 fasting triglyceride levels 61 A1c levels 61 μg L 61 nmol l 61 HbA1C 61 systolic blood pressure 61 lispro 60 #.#mg/dL 60 mmol 60 serum uric acid 60 OGTT 60 serum creatinine levels 60 A1C 60 creatinine ratio 60 alanine aminotransferase 60 nanograms per 60 μg dL 60 glycated hemoglobin levels 60 Hb A1C 60 prehypertensive 60 CrCl 60 triglyceride levels 60 ml kg 60 milligrams deciliter 60 hemoglobin A1C 60 mm Hg diastolic 59 LDL cholesterol levels 59 impaired fasting glucose 59 diastolic BP 59 creatinine clearance 59 diastolic pressure 59 A1C levels 59 elevated LDL cholesterol 59 #.#ng/ml 59 Cmax 59 alanine aminotransferase ALT 59 mIU mL 59 sUA 58 LDL 58 glycosylated hemoglobin 58 Fasting glucose 58 plasma glucose 58 tHcy 58 nmol 58 serum phosphorus 58 serum sodium 58 mU L 58 fasting glucose levels 58 serum glucose 58 transferrin saturation 58 cells uL 58 serum urate 58 ng dl 58 serum testosterone 58 #/#mmHg 58 Hb A1c 58 μg mL 58 eGFR 58 serum calcium 58 copies ml 58 nondiabetics 58 hemoglobin A1c levels 58 A1c 58 glycosylated hemoglobin HbA1c 57 Hb levels 57 mcg dL 57 Triglyceride levels 57 μmol l 57 urine albumin 57 #mg/day [001] 57 mL min 57 milliliter ng ml 57 highest tertile 57 fasting triglycerides 57 serum concentrations 57 mU liter 57 glycated hemoglobin HbA1c 57 nonfasting triglyceride levels 57 statistical significance p 57 #.#mmol L [001] 57 troponin T 57 serum IGF 57 #ng/ml 57 leukocyte count 57 aspartate aminotransferase AST 57 glomerular filtration rate 57 kg/m2 57 mIU ml 57 oral glucose tolerance 57 #.#mmHg 57 aspartate aminotransferase 57 HbA1C levels 57 LDL C 57 #OHD levels 57 bad cholesterol LDL 57 copies mL 56 lowest tertile 56 triglycerides ≥ 56 cells/mm3 56 serum triglycerides 56 CK MB 56 % CI #.#-#.# [003] 56 micromoles 56 nonfasting 56 hemoglobin concentrations 56 mcg mL 56 nondiabetic 56 ml min 56 diastolic blood pressures 56 diastolic blood pressure 56 systolic pressure 56 IU mL 56 mean baseline HbA1c 56 hemoglobin A1c 56 log# copies mL 56 prehypertension 56 μg d 56 μg liter 56 recurrent VTE 56 creatinine 56 systolic 56 insulin detemir 56 hs CRP 56 deciliter 56 hydroxyvitamin D levels 56 Fasting blood glucose 56 NovoLog ® Mix 56 baseline serum creatinine 56 neutrophil counts 56 normotensive 56 mcg kg 56 x ULN 56 mg orally 56 LDL cholesterol 56 glulisine 56 microalbuminuria 56 nanomoles per 56 HOMA IR 56 total cholesterol triglycerides 56 milligrams mg 55 #.#/#.# mmHg [001] 55 serum creatinine 55 plasma folate 55 mg QD 55 nondiabetic patients 55 antihypertensive medications 55 μg kg 55 HbA 1c levels 55 detemir 55 apnea hypopnea index 55 triglyceride TG 55 elevated CRP 55 thyrotropin levels 55 rizatriptan 55 nmol L. 55 per deciliter 55 albumin excretion 55 CD4 counts 55 fasting plasma glucose FPG 55 aminotransferases 55 CI -#.# 55 density lipoprotein cholesterol 55 iPTH 55 % CI #.#-#.# [004] 55 serum cholesterol 55 serum urate levels 55 advanced adenoma 55 pmol liter 55 triacylglycerol concentrations 55 mcg 55 elevated creatinine 55 PSA nadir 55 macroalbuminuria 55 systolic blood pressures 55 hsCRP levels 55 systolic dysfunction 55 lipid levels 55 mEq 55 triglyceride 55 serum phosphate 55 MADRS score 55 homocysteine concentrations 55 BENICAR HCT 55 NPH insulin 54 baseline Hb 54 mL kg 54 ug kg 54 plasma urate 54 adiponectin concentrations 54 albuminuria 54 Fasting glucose levels 54 plasma concentrations 54 SGPT 54 elevated uric acid 54 micrograms mcg 54 statin monotherapy 54 uric acid levels 54 diastolic hypertension 54 postprandial glucose 54 mcg BID 54 IU ml 54 μg ml 54 serum triglyceride levels 54 subclinical hypothyroidism 54 milliliters mL 54 glycemia 54 oral antidiabetic medication 54 glycaemia 54 μg dl 54 CI #.#-#.# [001] 54 mL/min/#.# m2 54 hours postdose 54 LANTUS R 54 serum phosphate levels 54 postprandial blood glucose 54 hypogonadal 54 triglycerides TG 54 hypoglycemia 54 lactate dehydrogenase LDH 54 hypokalemia 54 elevated triglycerides 54 % CI #.#-#.# [006] 54 sd = 54 serum HBV DNA 54 urinary albumin 54 serum TSH 54 total cholesterol LDL 54 specific antigen PSA 54 fructosamine 54 mm3 54 μg dose 54 cells μL 54 elevated fasting glucose 54 elevated ALT 54 ug dl 54 HDL C 54 % Confidence Interval 54 hypoglycemic episodes 54 urinary albumin excretion 54 milligrams 54 euthyroid 54 estimated glomerular filtration 54 #mg BID [003] 54 plasma triglycerides 54 benazepril 54 virologic failure 53 triglyceride concentration 53 Hemoglobin A1C 53 fasting insulin 53 elevated triglyceride levels 53 anemia hemoglobin 53 normal ULN 53 triglyceride concentrations 53 microg 53 antibody titer 53 serum potassium levels 53 X ULN 53 μg 53 HBeAg seroconversion 53 moderate renal impairment 53 Apidra ® 53 nonfatal MI 53 asymptomatic carotid stenosis 53 LVEF 53 nicardipine 53 DAS# [002] 53 HBV DNA levels 53 tertiles 53 mg 53 #mg/day [002] 53 serum LDL cholesterol 53 creatinine levels 53 NATRECOR R 53 3mg 53 peginterferon alfa 2a 53 sUA levels 53 #-# mg dl 53 severe neutropenia 53 blood glucose concentrations 53 insulin glargine 53 NT proBNP 53 proteinuria 53 ìg 53 plasma HCV RNA 53 advanced adenomas 53 #.#/#.# mm Hg [002] 53 mg TID 53 REYATAZ r arm 53 mg dose 53 severe renal impairment 53 severe hypoglycemia 53 unfractionated heparin 53 #.#/#.# mm Hg [003] 53 cTnI 53 PaO 2 53 Hb 53 titrated 53 aged ≥ 53 budesonide pMDI 53 adjunctive placebo 53 SpO 2 53 urinary oxalate 53 nocturnal hypoglycaemia 53 elevated serum creatinine 53 interquartile range 52 undetectable viral load 52 ug dL 52 gm dl 52 placebo p 52 millimoles per 52 -#.# ± [002] 52 mg BID 52 CC genotype 52 mg kg dose 52 rapid virological response 52 confidence interval #.#-#.# 52 comparator arm 52 hyperglycaemia 52 hypertensive patients 52 lipid concentrations 52 albumin excretion rate 52 baseline A1C 52 urate lowering therapy 52 abacavir lamivudine 52 fasting serum 52 SHBG levels 52 primary hypercholesterolemia 52 reinfarction 52 HGPIN 52 glargine 52 cardiovascular mortality 52 homocysteine levels 52 serum CRP 52 postprandial insulin 52 calculated creatinine clearance 52 #mm Hg 52 biochemical relapse 52 test OGTT 52 A1Cs 52 μg g 52 microlitre 52 serum albumin 52 lowering blood glucose 52 mg simvastatin 52 plasma leptin 52 CD4 count 52 mU 52 aminotransferase levels 52 BENICAR 52 sulphonylurea 52 serum triglyceride 52 density lipoprotein HDL cholesterol 52 serum cortisol 52 MMSE score 52 fraction LVEF 52 hemoglobin concentration 52 preserved ejection fraction 52 low density lipoprotein 52 #μg [001] 52 HDL Cholesterol 52 glucose concentrations 52 ejection fractions 52 antihypertensive therapy 52 serum vitamin D 52 adjunctive ABILIFY 52 nonfasting triglycerides 52 glomerular filtration 52 hypoglycemic events 52 transaminase levels 52 creatine kinase 52 Prehypertension 52 CDAI score 52 mg/m2 dose 52 C reactive protein 52 kg m² 52 μg l 52 blood sugar 52 serum magnesium 52 gastric pH 52 platelet count 52 MULTAQ 52 blood glucose levels 52 undetectable viral 52 Severe hypoglycemia 52 -#.# ± [001] 52 lopinavir r 52 μmol 52 EQUATE OB 52 candesartan cilexetil 52 CK # plasma concentrations 52 #mg/kg [002] 52 microliter 52 mmHg p = 52 periprocedural 52 pioglitazone 52 dapagliflozin plus 52 serum sodium levels 52 per decilitre 52 #mg [003] 52 HbA 1C 52 serum selenium 52 + PH# 52 NHANES III 52 left ventricular hypertrophy 51 undetectable HCV RNA 51 kcal d 51 mL 51 lumbar spine BMD 51 apolipoprotein B 51 urinary N telopeptide 51 nonobese 51 confidence interval CI 51 EDSS score 51 simvastatin #mg 51 gestational hypertension 51 metformin sulphonylurea 51 biphasic insulin aspart 51 polyp recurrence 51 FEV1 51 HDL cholesterol 51 uM 51 VLDL cholesterol 51 Serum creatinine 51 glucose tolerance test 51 statistically significant p 51 PREZISTA ritonavir 51 elevated blood glucose 51 Liver enzymes 51 nonfatal stroke 51 mEq L. 51 mcg dose 51 cholesterols 51 cholesterol triglyceride 51 ug mL 51 T2DM 51 IELT 51 folate intake 51 Hazard Ratio HR 51 BMI ≥ 51 fatal myocardial infarction 51 log# 51 ug ml 51 transaminase elevations 51 lymphocyte count 51 RLAI 51 LAB GHRH 51 hemoglobin Hb 51 mg RDEA# 51 elevated hsCRP 51 plasma uric acid 51 liver enzymes 51 hydroxyvitamin D 51 HCTZ 51 N telopeptide 51 severe exacerbations 51 creatine phosphokinase 51 resistant hypertension 51 hypophosphatemia 51 CDAI 51 AUC0 51 ALT elevations 51 anti HBs 51 serum bilirubin 51 mL sec 51 tipranavir r 51 mg m² 51 vitamin D2 51 atazanavir ritonavir 51 lopinavir r arm 51 serum phosphorous 51 serum phosphorus levels 51 tirofiban 51 serum homocysteine 51 estimated GFR 51 Median survival 51 Hemoglobin A1c HbA1c 51 cTnT 51 IIIa inhibitors 51 -#.# mg dL [001] 51 elevated LDL 51 -#.# mmol L 51 MetS 51 hyperglycemia 51 ertapenem 51 arterial thromboembolic events 51 cholesterol LDL 51 antibody titers 51 intima media thickness 51 circulating IGF 51 glimepiride 51 pCR 51 CIMZIA TM 51 antihypertensive medication 51 onset diabetes mellitus 51 sodium excretion 51 blood glucose 51 nM 51 transaminases 51 hyperlipidaemia 51 ARCOXIA 51 Index CDAI score 51 mg qd 51 thyrotropin 51 nondrinkers 51 postprandial glucose PPG 51 #.#g/day 51 serum sodium concentration 51 macrovascular 51 nonfatal myocardial infarction 51 left ventricular dysfunction 51 mg kg 51 TT genotype 51 transaminase elevations greater 51 hip BMD 51 dysfunction LVSD 51 isoprostane 51 fetuin 51 mg calcium 51 LDL triglycerides 51 ATACAND 51 fosamprenavir 51 oxycodone IR 51 hsCRP 51 allopurinol 51 atorvastatin #mg 51 % CI #.#-#.# [008] 51 intact parathyroid hormone 51 index BMI 51 Fasting plasma glucose 51 urinary sodium excretion 50 NOAEL 50 log# reduction 50 Baseline characteristics 50 inadequate glycemic 50 MBq 50 mcg kg min 50 eosinophil count 50 serum calcium levels 50 binary restenosis 50 CD4 + cell 50 NCEP ATP III 50 PREZISTA r 50 lipid lowering therapy 50 cTnT levels 50 ApoB 50 kg -1 50 serum PTH 50 serum PSA 50 μg doses 50 undetectable HBV DNA 50 serum lipid levels 50 thiazide diuretics 50 lipid lowering medications 50 maximally tolerated doses 50 mg tid 50 LDL Cholesterol 50 DAS# remission 50 serum retinol 50 curve AUC 50 cGy 50 Hemoglobin A1c 50 maintaining Hb 50 % CI #.#-#.# [007] 50 achieved ACR# 50 p = .# [002] 50 HCV RNA 50 poor metabolizers 50 preoperative PSA 50 ALT elevation 50 serum aminotransferase levels 50 rs# [002] 50 ejection fraction 50 magnesium intake 50 LDL cholesterol HDL cholesterol 50 isoflavone intake 50 P = .# 50 URTI 50 haemorrhagic stroke 50 LVSD 50 platelet reactivity 50 thromboembolic events 50 fasting plasma 50 triglycerides 50 #mg dose [003] 50 serum lactate 50 NSTE ACS 50 serum HCV RNA 50 KOMBIGLYZE XR 50 EpCAM expression 50 serum ferritin 50 β blocker 50 pg g 50 1c HbA 1c 50 nanograms milliliter 50 microvascular complications 50 left ventricular systolic 50 adenoma 50 LDL HDL 50 tertile 50 cubic millimeter 50 refractory ischemia 50 thyroid stimulating hormone 50 SGOT 50 asthma exacerbation 50 CI #.#-#.# [002] 50 GSTM1 50 seroconverted 50 isoenzyme 50 mg Androxal 50 thyroglobulin 50 BCG vaccinated 50 plasma homocysteine 50 endoscopic remission 50 cardiovascular hospitalizations 50 urate levels 50 severe hypoglycemic 50 mg metformin 50 posttransplant 50 protein excretion 50 IDDM 50 blood urea nitrogen 50 NNT = 50 hypertensives 50 endometrial thickness 50 sinus rhythm 50 Hazard Ratio = 50 acarbose 50 hypertensive 50 CCyR 50 tPSA 50 lipoprotein levels 50 kcals 50 gallstone disease 50 PASI scores 50 oxycodone CR 50 Bq/m3 50 QTcF 50 thyroxine 50 MMSE scores 50 hypopneas 50 LEXIVA r 50 colorectal adenoma 50 CLINICAL STUDIES 50 mcg albinterferon alfa 2b 50 serum ALT 50 mcg QD 50 rimonabant #mg 50 = #.#-#.# 50 HIV RNA 50 colorectal polyp 50 atherogenic dyslipidemia 50 mg eq 50 LV dysfunction 50 p = #.# [004] 50 APTIVUS r 50 cells mcL 50 HBeAg negative 50 stable angina 50 prescribed statin 50 irbesartan 50 hypocaloric diet 50 evaluable subjects 50 coronary revascularization 50 pmol 50 prolactin levels 50 HIV uninfected 50 #ug [001] 50 low dose Iluvien 50 ACTOplus met 50 biochemical recurrence 50 chlorthalidone 50 p = #.# [002] 50 cryptogenic 50 metformin monotherapy 50 hypoglycemic coma 50 EXJADE 50 fluticasone salmeterol 50 definite stent thrombosis 49 quetiapine 49 D dimer 49 milliliter ng mL 49 hematocrit 49 Pioglitazone 49 vertebral fracture 49 hypoglycaemia 49 recurrent atrial fibrillation 49 diastolic 49 PRADAXA #mg 49 valsartan 49 β blockers 49 n = 49 preintervention 49 #mg doses [002] 49 hypercholesterolemia 49 erythrocyte sedimentation rate 49 cilostazol 49 acrylamide intake 49 subclinical hyperthyroidism 49 Nicotinic acid 49 urinary calcium 49 cystatin C 49 OADs 49 methylmalonic acid 49 #.#mg/kg [002] 49 bilirubin liver 49 TC HDL 49 BLLs 49 candesartan 49 bezafibrate 49 p ≤ 49 peptide BNP 49 hydroxyvitamin D concentrations 49 metformin sulfonylurea 49 placebo 49 #-# mg dL 49 hyperkalemia 49 inhibin B 49 cortisol concentrations 49 serum prostate 49 micromol 49 infliximab monotherapy 49 alcoholic cirrhosis 49 bpm 49 mCi m 2 49 microliters 49 RYGB 49 overt hypothyroidism 49 bilirubin levels 49 systemic embolism 49 lymphocyte counts 49 statin therapy 49 PREZISTA r arm 49 detectable HCV RNA 49 blood phenylalanine Phe 49 baseline FEV 49 systolic diastolic blood 49 sitosterol 49 glipizide 49 micrograms 49 drank caffeinated 49 diuretic chlorthalidone 49 highest quintile 49 millimoles 49 Lp PLA2 49 alanine transaminase 49 leukopenia 49 RBC folate 49 International Normalized Ratio 49 noncarriers 49 corrected QT interval 49 PSADT 49 Homocysteine levels 49 serum estradiol 49 oxygen saturation 49 kcal 49 lipoprotein Lp 49 dose colchicine 49 antigen PSA 49 insulin degludec 49 Hgb 49 placebo p = 49 #OHD 49 platelet inhibition 49 amlodipine 49 tHcy concentrations 49 nanomolar 49 mg/# ml 49 min -1 49 mineral density 49 mcg doses 49 primary aldosteronism 49 Lipitor #mg 49 salmeterol fluticasone propionate 49 LDL cholesterol concentrations 49 alkaline phosphatase 49 elevated homocysteine 49 ACR# response 49 subcutaneous enoxaparin 49 Lantus R 49 Ramipril 49 cholesterol HDL 49 ritonavir boosted 49 fluvastatin 49 ipsilateral stroke 49 -#.# log# 49 eptifibatide 49 LS BMD 49 LEXIVA 49 urinary iodine 49 lactate dehydrogenase 49 LDL cholesterol triglycerides 49 IGFBP 49 certolizumab 49 statistically significant p = 49 cytarabine daunorubicin 49 angiotensin converting enzyme 49 serum testosterone levels 49 severe hypoglycaemia 49 aminotransferase ALT 49 chlorambucil 49 trans fat intake 49 elemental calcium 49 glycemic load 49 HDL2 49 #ug [002] 49 8mg 49 mg ustekinumab 49 thyroid stimulating hormone TSH 49 plasma glucose concentration 49 CVD mortality 49 Apgar scores 49 eplerenone 49 mg kg bw 49 NAFLD 49 virologic response 49 symptomatic GERD 49 microalbumin 49 rectal temperature 49 impaired glucose tolerance 49 IQR 49 Recommended Dietary Allowance 49 ug L 49 NYHA Class II 49 decilitre 49 per milliliter 49 EDSS scores 49 arterial oxygen saturation 49 median PFS 49 HDL LDL 49 abciximab 49 Kcal 49 ABC/3TC 49 glucose intolerance 49 dietary calcium intake 49 basal cell nevus syndrome 49 cerebrovascular events 49 oral antidiabetes 49 dysglycemia 48 pulmonary arterial 48 hyperphenylalaninemia HPA due 48 pCi l 48 micrograms mL 48 aOR 48 microgram kg 48 mg/m2/day 48 recurrent UTI 48 plasma lipids 48 mg dosed 48 Lantus ® 48 KDOQI 48 nonpregnant women 48 mcg ml 48 c reactive protein 48 osteopenic 48 LPV r 48 Stop Hypertension diet 48 cirrhotic patients 48 mg/m2 48 NovoMix ® 48 XIENCE V PROMUS Stent 48 mg dosed twice 48 adiponectin levels 48 mealtime insulin 48 prolonged QT interval 48 dietary fiber intake 48 administered subcutaneously 48 blood Phe 48 COZAAR 48 acetaminophen codeine 48 flutamide 48 procalcitonin 48 NYHA class 48 oral allopurinol 48 #mg #mg #mg [003] 48 lumiracoxib 48 gemfibrozil 48 GSTT1 48 unfractionated heparin UFH 48 folate concentrations 48 mg subcutaneously 48 SCr 48 mesalamine granules 48 beta blocker therapy 48 BMI #-#.# 48 QTc 48 hematological parameters 48 shorter telomere length 48 piperacillin tazobactam 48 mild renal impairment 48 Fibrates 48 serum GGT 48 gout flares 48 Plasma concentrations 48 ONGLYZA 48 Mg Uk 48 lipid abnormalities 48 bronchodilation 48 postoperative mortality 48 telmisartan 48 Primary endpoints 48 sustained virologic response 48 diabetes mellitus DM 48 Triglycerides 48 fasting lipid 48 density lipoprotein cholesterol HDL 48 receiving ISENTRESS 48 blood Phe levels 48 serum leptin 48 baseline LDH 48 receiving VELCADE 48 postprandial glycemia 48 SBP DBP 48 cfu 48 mg kg Hematide 48 progression TTP 48 DAS# CRP 48 TAXUS p value 48 diastolic readings 48 abacavir 48 d dimer 48 SHBG 48 abdominal adiposity 48 gliclazide 48 amoxicillin clavulanate 48 thromboembolic complications 48 Creatinine 48 MIC# [001] 48 micromolar 48 placebo dummy pill 48 titers 48 ergocalciferol 48 noncardiovascular mortality 48 colorectal neoplasia 48 IFN α 48 seroprotection 48 virological failure 48 thromboembolism 48 mixed dyslipidemia 48 fructose diet 48 insulin glulisine 48 ULORIC 48 hypogonadal men 48 #/#mg 48 platelet aggregation 48 atherothrombotic events 48 CMV infection 48 baseline CD4 48 sulfonylurea 48 p = #.# [003] 48 ASCUS 48 isolated systolic hypertension